Ocular Therapeutix, Inc (OCUL) insider trading
Every open-market stock purchase and sale by Ocular Therapeutix, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $461K over the last 12 months (1 buy).
- Insiders sold $3.1M over the last 12 months (23 sales).
- Last insider buy: Richard L Lindstrom Md (Director), $461K, 7 months ago.
Last 12 months: insiders bought $461K (1 buy) and sold $3.1M (23 sales). Last close $8.25 on Jun 4, 2026.
Recent OCUL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 16, 2026 | Pravin Dugel (Officer) | Bought (not open market) | — |
| Jun 10, 2026 | Merilee Raines (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Seung Suh Hong (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Charles M Warden (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Charles M Warden (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Jason Shand Robins (CFO) | Bought (not open market) | — |
| Jun 10, 2026 | Jason Shand Robins (CFO) | Bought (not open market) | — |
| Jun 10, 2026 | Adrienne L Graves (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Merilee Raines (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Leslie J. Williams (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Leslie J. Williams (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Adrienne L Graves (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Seung Suh Hong (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Richard L Lindstrom Md (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Richard L Lindstrom Md (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Nadia Waheed (C-suite exec) | Sold | $123K |
| May 28, 2026 | Pravin Dugel (Officer) | Bought (not open market) | — |
| May 26, 2026 | Pravin Dugel (Officer) | Sold | $173K |
| May 26, 2026 | Jeffrey S. Heier (C-suite exec) | Sold | $24.7K |
| May 26, 2026 | Peter Kaiser (C-suite exec) | Sold | $24.3K |
| May 26, 2026 | Sanjay Nayak (C-suite exec) | Sold | $15.2K |
| Apr 9, 2026 | Pravin Dugel (Officer) | Bought (not open market) | — |
| Feb 23, 2026 | Pravin Dugel (Officer) | Sold | $166K |
| Feb 23, 2026 | Jeffrey S. Heier (C-suite exec) | Sold | $25.3K |
| Feb 23, 2026 | Peter Kaiser (C-suite exec) | Sold | $23.3K |
Who's trading OCUL
- Pravin Dugel, Officer: sold $1.7M (4 sales), last Jun 16, 2026
- Adrienne L Graves, Director: other filings, last Jun 10, 2026
- Jason Shand Robins, CFO: other filings, last Jun 10, 2026
- Seung Suh Hong, Director: other filings, last Jun 10, 2026
- Richard L Lindstrom Md, Director: bought $461K (1 buy), last Jun 10, 2026
- Leslie J. Williams, Director: other filings, last Jun 10, 2026
- Charles M Warden, Director: other filings, last Jun 10, 2026
- Merilee Raines, Director: other filings, last Jun 10, 2026
- Nadia Waheed, C-suite exec: sold $221K (3 sales), last Jun 3, 2026
- Jeffrey S. Heier, C-suite exec: sold $208K (4 sales), last May 26, 2026
- Sanjay Nayak, C-suite exec: sold $146K (4 sales), last May 26, 2026
- Peter Kaiser, C-suite exec: sold $190K (4 sales), last May 26, 2026
- Donald Notman, Officer: sold $205K (3 sales), last Feb 12, 2026
- David Wayne Robinson, C-suite exec: other filings, last Jan 21, 2026
- Todd Anderman, C-suite exec: sold $137K (1 sale), last Jan 2, 2026
Get free alerts when an insider at Ocular Therapeutix, Inc files a new trade →